5UZA image
Deposition Date 2017-02-25
Release Date 2018-02-28
Last Version Date 2024-03-06
Entry Detail
PDB ID:
5UZA
Keywords:
Title:
Adenine riboswitch aptamer domain labelled with iodo-uridine by position-selective labelling of RNA (PLOR)
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.22 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polyribonucleotide
Molecule:RNA (71-MER)
Chain IDs:A (auth: X)
Chain Length:71
Number of Molecules:1
Biological Source:Vibrio vulnificus
Primary Citation
Incorporation of isotopic, fluorescent, and heavy-atom-modified nucleotides into RNAs by position-selective labeling of RNA.
Nat Protoc 13 987 1005 (2018)
PMID: 29651055 DOI: 10.1038/nprot.2018.002

Abstact

Site-specific incorporation of labeled nucleotides is an extremely useful synthetic tool for many structural studies (e.g., NMR, electron paramagnetic resonance (EPR), fluorescence resonance energy transfer (FRET), and X-ray crystallography) of RNA. However, specific-position-labeled RNAs >60 nt are not commercially available on a milligram scale. Position-selective labeling of RNA (PLOR) has been applied to prepare large RNAs labeled at desired positions, and all the required reagents are commercially available. Here, we present a step-by-step protocol for the solid-liquid hybrid phase method PLOR to synthesize 71-nt RNA samples with three different modification applications, containing (i) a 13C15N-labeled segment; (ii) discrete residues modified with Cy3, Cy5, or biotin; or (iii) two iodo-U residues. The flexible procedure enables a wide range of downstream biophysical analyses using precisely localized functionalized nucleotides. All three RNAs were obtained in <2 d, excluding time for preparing reagents and optimizing experimental conditions. With optimization, the protocol can be applied to other RNAs with various labeling schemes, such as ligation of segmentally labeled fragments.

Legend

Protein

Chemical

Disease

Primary Citation of related structures